Cristiana Sessa, MD | Authors


Targeted Therapies for Patients With Ovarian Cancer Who Have BRCA-Mutated Tumors

January 26, 2018

Cristiana Sessa, MD, head of Phase I-II Unit and Pharmacology, vice head of Medical Oncology and Head of Clinical Research, Oncology Institute of Southern Switzerland, discusses targeted therapies for BRCA1/2-mutated tumors.